3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators
US7655670B2 · kind B2 · utility
3Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 25, 2006 |
| Grant date | Feb 2, 2010 |
| Priority date | — |
| Expiry date | Sep 5, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel 3-spirocyclic indolyl derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the ORL-1 receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.